Vivera Pharmaceuticals Licenses TABMELT®, a Sublingual Pharmaceutical Drug-Delivery System for Cannabidiol (CBD)
Company to focus on benefits of CBD for non-addictive pain management and opioid, alcohol addiction recovery NEWPORT BEACH, Calif.–(BUSINESS WIRE)– Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the debut of TABMELT®, a sublingual drug delivery system that Vivera has exclusively licensed for the specific use for pharmaceutical cannabinoids, including […]
